# Modulatory Effects of Urtica dioica on Neurodegenerative Diseases: Unveiling the Latest Findings and Applications Related to Neuroinflammation, Oxidative Stress, and Cognitive Dysfunction

**Authors:** Ahlem Chira, Stefano Lorenzetti

PMC · DOI: 10.3390/antiox14070854 · 2025-07-12

## TL;DR

This paper reviews how Urtica dioica may help treat neurodegenerative diseases by reducing inflammation, oxidative stress, and cognitive decline.

## Contribution

The paper provides a novel synthesis of Urtica dioica's phytochemical effects on neurodegenerative pathways and cognitive function.

## Key findings

- Urtica dioica's phytochemicals reduce neuroinflammation and oxidative stress in neurodegenerative diseases.
- Flavonoids and polyphenols in Urtica dioica support neuronal plasticity and cognitive function.
- The plant shows potential for neuroprotection in Alzheimer’s, Parkinson’s, and Multiple Sclerosis.

## Abstract

Over the past decade, Urtica dioica L. (U. dioica) has gained prominence in biomedical research, particularly for its potential therapeutic applications in neurodegenerative diseases. This comprehensive review explores its botanical characteristics, toxicological considerations, and extensive traditional medicinal uses. Emphasizing the roles of phytochemical constituents such as flavonoids and overall polyphenolic compounds, this review examines their impact on mitigating critical pathways, such as neuroinflammation, oxidative stress, and mitochondrial dysfunction—all of which are implicated in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and Multiple Sclerosis (MS)—and, overall, in neurodegenerative processes in both humans and animal models. Notably, some phytochemicals are known to modulate crucial pathways for neuronal plasticity, learning, and memory, thereby enhancing cognitive functions. Hence, the potential of U. dioica-based therapies to improve cognitive function and pave the way for future therapeutic developments in neuroprotection is underscored.

## Linked entities

- **Diseases:** Alzheimer’s Disease (MONDO:0004975), Parkinson’s Disease (MONDO:0005180), Multiple Sclerosis (MONDO:0005301)
- **Species:** Urtica dioica (taxon 3501), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** AD (MESH:D000544), MS (MESH:D009103), Cognitive Dysfunction (MESH:D003072), mitochondrial dysfunction (MESH:D028361), Neurodegenerative Diseases (MESH:D019636), Neuroinflammation (MESH:D000090862), PD (MESH:D010300)
- **Chemicals:** flavonoids (MESH:D005419), polyphenolic compounds (-)
- **Species:** Urtica dioica (great nettle, species) [taxon 3501], Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12292394/full.md

---
Source: https://tomesphere.com/paper/PMC12292394